Flagship Ventures Opportunities Fund I General Partner Llc - Net Worth and Insider Trading
Flagship Ventures Opportunities Fund I General Partner Llc Net Worth
The estimated net worth of Flagship Ventures Opportunities Fund I General Partner Llc is at least $124 Million dollars as of 2024-09-20. Flagship Ventures Opportunities Fund I General Partner Llc is the 10% Owner of Foghorn Therapeutics Inc and owns about 12,674,120 shares of Foghorn Therapeutics Inc (FHTX) stock worth over $124 Million. Details can be seen in Flagship Ventures Opportunities Fund I General Partner Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Flagship Ventures Opportunities Fund I General Partner Llc has not made any transactions after 2020-10-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Flagship Ventures Opportunities Fund I General Partner Llc
Flagship Ventures Opportunities Fund I General Partner Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Flagship Ventures Opportunities Fund I General Partner Llc owns 5 companies in total, including Foghorn Therapeutics Inc (FHTX) , Evelo Biosciences Inc (EVLO) , and Kaleido Biosciences Inc (KLDO) among others .
Insider Ownership Summary of Flagship Ventures Opportunities Fund I General Partner Llc
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
FHTX | Foghorn Therapeutics Inc | 2020-10-27 | 10 percent owner |
EVLO | Evelo Biosciences Inc | 2018-05-08 | 10 percent owner |
KLDO | Kaleido Biosciences Inc | 2019-02-27 | 10 percent owner |
2020-05-18 | 10 percent owner | ||
2021-03-19 | 10 percent owner |
Flagship Ventures Opportunities Fund I General Partner Llc Latest Holdings Summary
Flagship Ventures Opportunities Fund I General Partner Llc currently owns a total of 1 stock. Flagship Ventures Opportunities Fund I General Partner Llc owns 12,674,120 shares of Foghorn Therapeutics Inc (FHTX) as of October 27, 2020, with a value of $124 Million.
Latest Holdings of Flagship Ventures Opportunities Fund I General Partner Llc
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
FHTX | Foghorn Therapeutics Inc | 2020-10-27 | 12,674,120 | 9.81 | 124,333,117 |
Holding Weightings of Flagship Ventures Opportunities Fund I General Partner Llc
Flagship Ventures Opportunities Fund I General Partner Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Flagship Ventures Opportunities Fund I General Partner Llc has made a total of 1 transactions in Foghorn Therapeutics Inc (FHTX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Foghorn Therapeutics Inc is the acquisition of 150,000 shares on October 27, 2020, which cost Flagship Ventures Opportunities Fund I General Partner Llc around $2 Million.
Insider Trading History of Flagship Ventures Opportunities Fund I General Partner Llc
- 1
Flagship Ventures Opportunities Fund I General Partner Llc Trading Performance
GuruFocus tracks the stock performance after each of Flagship Ventures Opportunities Fund I General Partner Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Flagship Ventures Opportunities Fund I General Partner Llc is 8.94%. GuruFocus also compares Flagship Ventures Opportunities Fund I General Partner Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Flagship Ventures Opportunities Fund I General Partner Llc within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Flagship Ventures Opportunities Fund I General Partner Llc's insider trading performs compared to the benchmark.
Performance of Flagship Ventures Opportunities Fund I General Partner Llc
Flagship Ventures Opportunities Fund I General Partner Llc Ownership Network
Flagship Ventures Opportunities Fund I General Partner Llc Owned Company Details
What does Foghorn Therapeutics Inc do?
Who are the key executives at Foghorn Therapeutics Inc?
Flagship Ventures Opportunities Fund I General Partner Llc is the 10 percent owner of Foghorn Therapeutics Inc. Other key executives at Foghorn Therapeutics Inc include Chief People Officer Carlos Costa , See Remarks Steven F. Bellon , and Chief Strategy/Bus Ops Officer Fanny Cavalie .
Foghorn Therapeutics Inc (FHTX) Insider Trades Summary
Over the past 18 months, Flagship Ventures Opportunities Fund I General Partner Llc made no insider transaction in Foghorn Therapeutics Inc (FHTX). Other recent insider transactions involving Foghorn Therapeutics Inc (FHTX) include a net sale of 311,297 shares made by Samuel Agresta , a net sale of 20,000 shares made by Steven F. Bellon , and a net sale of 11,000 shares made by Fanny Cavalie .
In summary, during the past 3 months, insiders sold 30,672 shares of Foghorn Therapeutics Inc (FHTX) in total and bought 0 shares, with a net sale of 30,672 shares. During the past 18 months, 352,969 shares of Foghorn Therapeutics Inc (FHTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 352,969 shares.
Foghorn Therapeutics Inc (FHTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Foghorn Therapeutics Inc Insider Transactions
Flagship Ventures Opportunities Fund I General Partner Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Flagship Ventures Opportunities Fund I General Partner Llc. You might contact Flagship Ventures Opportunities Fund I General Partner Llc via mailing address: 55 Cambridge Parkway, Suite 800e, Cambridge Ma 02142.